Association of Life's Essential 8 with incident atherosclerotic cardiovascular disease in cancer patients: the Kailuan prospective cohort study.
- Published in:
- 2023
- By:
- Publication type:
- Letter
Works matching IS 20474873 AND DT 2023 AND VI 30 AND IP 17
Results: 15
1
2
Should we continue to subsidise therapeutics with uncertain efficacy? Health economic implications for icosapent ethyl.
- Published in:
- European Journal of Preventive Cardiology, 2023, v. 30, n. 17, p. 1935, doi. 10.1093/eurjpc/zwac212
- By:
- Publication type:
- Article
3
Effect of dual lipid-lowering therapy on coronary plaques in patients with coronary artery disease: systematic review and meta-analysis.
- Published in:
- 2023
- By:
- Publication type:
- Letter
4
Effect of lipoprotein(a) levels on coronary lesion complexity in patients with acute myocardial infarction: data from the French RICO survey.
- Published in:
- 2023
- By:
- Publication type:
- Letter
5
Cumulative remnant cholesterol predicts cardiovascular outcomes in elderly patients with atherosclerotic cardiovascular disease.
- Published in:
- European Journal of Preventive Cardiology, 2023, v. 30, n. 17, p. 1924, doi. 10.1093/eurjpc/zwad297
- By:
- Publication type:
- Article
6
Association of cumulative remnant cholesterol with incident adverse cardiovascular events in the elderly: another piece in the puzzle.
- Published in:
- 2023
- By:
- Publication type:
- Editorial
7
Effects of weight loss in heart failure patients with overweight and obesity: a systematic review and meta-analysis.
- Published in:
- European Journal of Preventive Cardiology, 2023, v. 30, n. 17, p. 1906, doi. 10.1093/eurjpc/zwad284
- By:
- Publication type:
- Article
8
Down the rabbit hole: reviewing the evidence for primary prevention of cardiovascular disease in people with obesity.
- Published in:
- European Journal of Preventive Cardiology, 2023, v. 30, n. 17, p. 1895, doi. 10.1093/eurjpc/zwad280
- By:
- Publication type:
- Article
9
The effect of statins on mortality and cardiovascular disease in primary care hypertensive patients without other cardiovascular disease or diabetes.
- Published in:
- European Journal of Preventive Cardiology, 2023, v. 30, n. 17, p. 1883, doi. 10.1093/eurjpc/zwad212
- By:
- Publication type:
- Article
10
Real-world data show the effect of statins in primary prevention.
- Published in:
- 2023
- By:
- Publication type:
- Editorial
11
Modelling the potential long-term survival benefit of evinacumab treatment vs. standard of care in patients with homozygous familial hypercholesterolaemia.
- Published in:
- European Journal of Preventive Cardiology, 2023, v. 30, n. 17, p. 1874, doi. 10.1093/eurjpc/zwad203
- By:
- Publication type:
- Article
12
Use of new paediatric VO<sub>2max</sub> reference equations to evaluate aerobic fitness in overweight or obese children with congenital heart disease.
- Published in:
- European Journal of Preventive Cardiology, 2023, v. 30, n. 17, p. 1865, doi. 10.1093/eurjpc/zwad201
- By:
- Publication type:
- Article
13
Comparison of the European and US guidelines for lipid-lowering therapy in primary prevention of cardiovascular disease.
- Published in:
- European Journal of Preventive Cardiology, 2023, v. 30, n. 17, p. 1856, doi. 10.1093/eurjpc/zwad193
- By:
- Publication type:
- Article
14
Cardiovascular risk assessment: are we getting all the information we need?
- Published in:
- 2023
- By:
- Publication type:
- Editorial
15
Editorial comments: focus on lipid lowering and weight loss role in cardiovascular prevention.
- Published in:
- 2023
- By:
- Publication type:
- Editorial